The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.
Andrew K Takle, Murray J B Brown, Susannah Davies, David K Dean, Gerraint Francis, Alessandra Gaiba, Alex W Hird, Frank D King, Peter J Lovell, Antoinette Naylor, Alastair D Reith, Jon G Steadman, David M Wilson
Index: Bioorg. Med. Chem. Lett. 16(2) , 378-381, (2006)
Full Text: HTML
Abstract
A novel triarylimidazole derivative, SB-590885 (33), bearing a 2,3-dihydro-1H-inden-1-one oxime substituent has been identified as a potent and extremely selective inhibitor of B-Raf kinase.
Related Compounds
Related Articles:
2011-06-23
[J. Med. Chem. 54 , 4219-4233, (2011)]
2000-06-01
[Bioorg. Med. Chem. 8(6) , 1245-52, (2000)]
2006-03-15
[Bioorg. Med. Chem. Lett. 16(6) , 1532-1536, (2006)]
2001-01-01
[J. Org. Chem. 64(1) , 120-125, (1999)]
Enzymatic Baeyer-Villiger Oxidation of Benzo-Fused Ketones: Formation of Regiocomplementary Lactones. Rioz-Martinez A, et al.
[European J. Org. Chem. 2009(15) , 2526-2532, (2009)]